๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX ยท Real-Time Price ยท USD
1.500
-0.090 (-5.66%)
At close: Nov 19, 2026, 4:00 PM EST
1.450
-0.050 (-3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST

Elicio Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-38.33-37.71-44.99-35.75-23.73-25.47
Net Income
-35.74-39.57-51.9-35.2-28.21-26.4
Earnings Per Share
-1.80-2.58-4.25-6.96-89.27-1.73
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
30.918.5617.6212.896.169.28
Total Debt
13.9914.5126.046.927.4811.8
Net Cash (Debt)
16.914.05-8.425.98-1.33-2.52
Net Cash Growth
204.45%-----
Net Cash Per Share
0.850.26-0.691.18-4.19-0.16

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-36.97-36.95-37.07-32.69-22.18-23.94
Capital Expenditures
-0.02-0.02-0.09-0.07-0.65-0.53
Free Cash Flow
-36.99-36.97-37.16-32.76-22.83-24.46
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.